

Shares of Adicet Bio are trading lower after the clinical stage biotechnology company announced a one-for-16 reverse stock split.
You can purchase shares of Adicet Bio (NASDAQ:ACET) through any online brokerage.
Other companies in Adicet Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Adicet Bio has a consensus price target of $52.14.
The stock price for Adicet Bio (NASDAQ: ACET) is $3.1 last updated November 4, 2026 at 4:00 PM EST.
There are no upcoming dividends for Adicet Bio.
Adicet Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Adicet Bio.
Adicet Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric...